Literature DB >> 25760541

Novel single nucleotide polymorphisms of the dihydropyrimidinase gene (DPYS) in Japanese individuals.

Fumika Akai1, Hiroki Hosono1, Noriyasu Hirasawa1, Masahiro Hiratsuka2.   

Abstract

Genetic polymorphisms of the dihydropyrimidinase gene (DPYS) may be associated with the development of severe toxicity to 5-fluorouracil, a drug used to treat solid tumors. In this study, we analyzed the nine coding exons and exon-intron junctions of DPYS in 183 Japanese individuals. We detected two novel single nucleotide polymorphisms (SNPs)-285C > T (Thr95Thr) and 349T > C (Trp117Arg)-in exon 2. The nonsynonymous SNP 349T > C was analyzed in 208 Japanese individuals. Although the allele frequency of the SNP in the Japanese population was found to be extremely low (0.13%), the enzymatic activity of the variant protein might be reduced compared with that of the wild-type protein.
Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DPYS; Dihydropyrimidinase; Genetic polymorphism; Japanese; SNP

Mesh:

Substances:

Year:  2014        PMID: 25760541     DOI: 10.1016/j.dmpk.2014.09.005

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  2 in total

1.  Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population.

Authors:  Eiji Hishinuma; Yoko Narita; Kai Obuchi; Akiko Ueda; Sakae Saito; Shu Tadaka; Kengo Kinoshita; Masamitsu Maekawa; Nariyasu Mano; Noriyasu Hirasawa; Masahiro Hiratsuka
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Genome-wide scan identifies novel genetic loci regulating salivary metabolite levels.

Authors:  Abhishek Nag; Yuko Kurushima; Ruth C E Bowyer; Philippa M Wells; Stefan Weiss; Maik Pietzner; Thomas Kocher; Johannes Raffler; Uwe Völker; Massimo Mangino; Timothy D Spector; Michael V Milburn; Gabi Kastenmüller; Robert P Mohney; Karsten Suhre; Cristina Menni; Claire J Steves
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.